59 related articles for article (PubMed ID: 35116770)
21. Numb inhibits cell proliferation, invasion, and epithelial-mesenchymal transition through PAK1/β-catenin signaling pathway in ovarian cancer.
Liang J; Han B; Zhang Y; Yue Q
Onco Targets Ther; 2019; 12():3223-3233. PubMed ID: 31114254
[TBL] [Abstract][Full Text] [Related]
22. Ligustrazine inhibits the proliferation and migration of ovarian cancer cells via regulating miR-211.
Zhang H; Ding S; Xia L
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33245099
[TBL] [Abstract][Full Text] [Related]
23. TMCO1 regulates cell proliferation, metastasis and EMT signaling through CALR, promoting ovarian cancer progression and cisplatin resistance.
Sun G; Gong S; Lan S; He Y; Sun Y; Zhang Z
Cell Mol Biol (Noisy-le-grand); 2024 Jan; 70(1):99-109. PubMed ID: 38372107
[TBL] [Abstract][Full Text] [Related]
24. βKlotho inhibits androgen/androgen receptor‑associated epithelial‑mesenchymal transition in prostate cancer through inactivation of ERK1/2 signaling.
Liu Z; Zhang H; Ding S; Qi S; Liu S; Sun D; Dong W; Yin L; Li M; Zhao X; Lu J
Oncol Rep; 2018 Jul; 40(1):217-225. PubMed ID: 29749458
[TBL] [Abstract][Full Text] [Related]
25. Nrf2 antioxidant pathway suppresses Numb-mediated epithelial-mesenchymal transition during pulmonary fibrosis.
Zhang Z; Qu J; Zheng C; Zhang P; Zhou W; Cui W; Mo X; Li L; Xu L; Gao J
Cell Death Dis; 2018 Jan; 9(2):83. PubMed ID: 29362432
[TBL] [Abstract][Full Text] [Related]
26. Front-line therapy of advanced epithelial ovarian cancer: standard treatment.
Marth C; Reimer D; Zeimet AG
Ann Oncol; 2017 Nov; 28(suppl_8):viii36-viii39. PubMed ID: 29232473
[TBL] [Abstract][Full Text] [Related]
27. Numb prevents a complete epithelial-mesenchymal transition by modulating Notch signalling.
Bocci F; Jolly MK; Tripathi SC; Aguilar M; Hanash SM; Levine H; Onuchic JN
J R Soc Interface; 2017 Nov; 14(136):. PubMed ID: 29187638
[TBL] [Abstract][Full Text] [Related]
28. Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer.
Kritsch D; Hoffmann F; Steinbach D; Jansen L; Mary Photini S; Gajda M; Mosig AS; Sonnemann J; Peters S; Melnikova M; Thomale J; Dürst M; Runnebaum IB; Häfner N
Int J Cancer; 2017 Oct; 141(8):1600-1614. PubMed ID: 28670762
[TBL] [Abstract][Full Text] [Related]
29. [Expression and Clinical Significance of Numb and P53 Proteins in Epithelial Ovarian Carcinoma].
Xu M; He HJ; Zhang H; Wang A; Chen J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 48(1):76-80. PubMed ID: 28612563
[TBL] [Abstract][Full Text] [Related]
30. [Expression Level of Membrane-associated Proteins Numb in Epithelial Ovarian Carcinoma and Its Relationship with Ovarian Cancer Stem Cell Markers CD117, CD133, ALDH1.].
Jing H; Liu XY; Chen YL; Bai LP; Zheng A
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):878-882. PubMed ID: 28598117
[TBL] [Abstract][Full Text] [Related]
31. Pre-clinical validation of a selective anti-cancer stem cell therapy for Numb-deficient human breast cancers.
Tosoni D; Pambianco S; Ekalle Soppo B; Zecchini S; Bertalot G; Pruneri G; Viale G; Di Fiore PP; Pece S
EMBO Mol Med; 2017 May; 9(5):655-671. PubMed ID: 28298340
[TBL] [Abstract][Full Text] [Related]
32. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
33. NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling.
Zhang J; Shao X; Sun H; Liu K; Ding Z; Chen J; Fang L; Su W; Hong Y; Li H; Li H
Oncotarget; 2016 Sep; 7(38):61036-61053. PubMed ID: 27506933
[TBL] [Abstract][Full Text] [Related]
34. NUMB inactivation confers resistance to imatinib in chronic myeloid leukemia cells.
García-Alegría E; Lafita-Navarro MC; Aguado R; García-Gutiérrez L; Sarnataro K; Ruiz-Herguido C; Martín F; Bigas A; Canelles M; León J
Cancer Lett; 2016 May; 375(1):92-99. PubMed ID: 26944313
[TBL] [Abstract][Full Text] [Related]
35. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic mechanisms and therapeutic targets of chemotherapy resistance in epithelial ovarian cancer.
Borley J; Brown R
Ann Med; 2015; 47(5):359-69. PubMed ID: 26158617
[TBL] [Abstract][Full Text] [Related]
37. Numb Protects Human Renal Tubular Epithelial Cells From Bovine Serum Albumin-Induced Apoptosis Through Antagonizing CHOP/PERK Pathway.
Ding X; Ma M; Teng J; Shao F; Wu E; Wang X
J Cell Biochem; 2016 Jan; 117(1):163-71. PubMed ID: 26096024
[TBL] [Abstract][Full Text] [Related]
38. Numb induces e-cadherin adhesion dissolution, cytoskeleton reorganization, and migration in tubular epithelial cells contributing to renal fibrosis.
Ding X; Ma M; Teng J; Shao F; Teng RK; Zhou S; Zhang Y; Wu E; Wang X
Curr Mol Med; 2015; 15(4):368-79. PubMed ID: 25941814
[TBL] [Abstract][Full Text] [Related]
39. A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma.
Selle F; Sevin E; Ray-Coquard I; Mari V; Berton-Rigaud D; Favier L; Fabbro M; Lesoin A; Lortholary A; Pujade-Lauraine E
Ann Oncol; 2014 Nov; 25(11):2191-2196. PubMed ID: 25210017
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
